ArticleJournal of the Chinese Medical Association : JCMA2022
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis.
Chen-Hua Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.